2021
DOI: 10.1155/2021/6901131
|View full text |Cite
|
Sign up to set email alerts
|

BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age

Abstract: Vaccinations are the most important intervention for controlling the ongoing coronavirus disease (COVID-19) pandemic, caused by the SARS-CoV-2 virus. BNT162b2 is an mRNA-based vaccine, which is promising and safe for use during pregnancy, as it could help prevent SARS-CoV-2 infection and its complications during pregnancy. Other vaccines, such as influenza and Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccines, provide significant protection for babies. Recent studies have shown… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1
1

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(23 citation statements)
references
References 28 publications
0
18
0
Order By: Relevance
“…A flowchart of study selection process is reported in Figure 2 . We considered 46 records: 30 of them included pregnant mothers [ 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 ], two studies included both pregnant and lactating mothers [ 39 , 40 ], and 14 studies included lactating mothers [ 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 ]. Most studies were conducted in the United States (41.3%) and Israel (26.1%), along with three in Italy (6.5%), two in Spain (4.3%) and in Poland (4.3%), and the remaining (17.2%) in the United Kingdom, Qatar, Belgium, Germany, Norway, Portugal, the Netherlands, and Singapore.…”
Section: Resultsmentioning
confidence: 99%
“…A flowchart of study selection process is reported in Figure 2 . We considered 46 records: 30 of them included pregnant mothers [ 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 ], two studies included both pregnant and lactating mothers [ 39 , 40 ], and 14 studies included lactating mothers [ 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 ]. Most studies were conducted in the United States (41.3%) and Israel (26.1%), along with three in Italy (6.5%), two in Spain (4.3%) and in Poland (4.3%), and the remaining (17.2%) in the United Kingdom, Qatar, Belgium, Germany, Norway, Portugal, the Netherlands, and Singapore.…”
Section: Resultsmentioning
confidence: 99%
“…Ten of the 32 (31%) studies (Figure 2) in pregnant people examined the immunogenicity or the ability of the COVID-19 vaccine to elicit an immune response. 21,28,[37][38][39][40][41][42][43][44] These studies demonstrated that COVID-19 vaccination during pregnancy produced a robust immune response, and the antibody production was similar to those of non-pregnant people. 21,39 These antibodies were also found in umbilical cord blood, 21,37,[40][41][42][43][44] which means COVID-19 vaccination during pregnancy may convey some immunity to neonates against COVID-19.…”
Section: Covid-19 Vaccine Immunogenicity and Effectivenessmentioning
confidence: 99%
“…21,28,[37][38][39][40][41][42][43][44] These studies demonstrated that COVID-19 vaccination during pregnancy produced a robust immune response, and the antibody production was similar to those of non-pregnant people. 21,39 These antibodies were also found in umbilical cord blood, 21,37,[40][41][42][43][44] which means COVID-19 vaccination during pregnancy may convey some immunity to neonates against COVID-19. In addition, the highest maternal and umbilical cord antibody levels were achieved through the completion of a full vaccination series and a booster dose.…”
Section: Covid-19 Vaccine Immunogenicity and Effectivenessmentioning
confidence: 99%
“…The major scientific societies in the world recommend vaccination to those who are pregnant and breastfeeding. Vaccinating pregnant women offers an opportunity to provide protection to immunologically immature infants before they can receive their own vaccinations [ 196 ]. There is no certainty of pregnancy interruption in women who received vaccination before discovering they were already pregnant [ 47 ].…”
Section: Vaccinesmentioning
confidence: 99%